FDA Clearance Tracker · K240296
Tulsa Pro System (Pad-105)
Last checked: Nov 19, 2026Latest source record: May 9, 2024 (this decision)Source: openFDAMethods & limitations
Decided
May 9, 2024
Substantially Equivalent
Time to decision
98 days
Received Feb 1, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K240296
- Device name
- Tulsa Pro System (Pad-105)
- Applicant
- Profound Medical, Inc.
- Applicant location
- Mississauga, CA
- Received
- Feb 1, 2024
- Decided
- May 9, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.4340
- Specialty
- GI, Urology & NephrologyUrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code PLP. The earliest in FDA's data is DEN150011, decided Oct 9, 2015.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K240296
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Profound Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- TULSA-PRO System510(k)
K230692 · Decided Sep 20, 2023 · 191 days after receipt
Device type: High Intensity Ultrasound System For Prostate Tissue Ablation (PLP) · GI, Urology & Nephrology
- TULSA-PRO System510(k)
K211858 · Decided Sep 6, 2022 · 447 days after receipt
Device type: High Intensity Ultrasound System For Prostate Tissue Ablation (PLP) · GI, Urology & Nephrology
- Tulsa-Pro System510(k)
K202286 · Decided Sep 16, 2020 · 35 days after receipt
Device type: High Intensity Ultrasound System For Prostate Tissue Ablation (PLP) · GI, Urology & Nephrology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.